Frequent loss of cystatin E/M expression implicated in the progression of prostate cancer.
about
TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunities.Genome-wide unmasking of epigenetically silenced genes in lung adenocarcinoma from smokers and never smokersMutations in protein-binding hot-spots on the hub protein Smad3 differentially affect its protein interactions and Smad3-regulated gene expressionCellular phenotype-dependent and -independent effects of vitamin C on the renewal and gene expression of mouse embryonic fibroblastsA closed-tube methylation-sensitive high resolution melting assay (MS-HRMA) for the semi-quantitative determination of CST6 promoter methylation in clinical samples.Relative quantification of serum proteins from pancreatic ductal adenocarcinoma patients by stable isotope dilution liquid chromatography-mass spectrometry.In Silico Analysis Validates Proteomic Findings of Formalin-fixed Paraffin Embedded Cutaneous Squamous Cell Carcinoma Tissue.Differential secretome analysis reveals CST6 as a suppressor of breast cancer bone metastasisCharacterization of long noncoding RNA and messenger RNA signatures in melanoma tumorigenesis and metastasis.Interleukin-6 Induced "Acute" Phenotypic Microenvironment Promotes Th1 Anti-Tumor Immunity in Cryo-Thermal Therapy Revealed By Shotgun and Parallel Reaction Monitoring Proteomics.Proteolytic cleavage and truncation of NDRG1 in human prostate cancer cells, but not normal prostate epithelial cells.Cystatin E/M Suppresses Tumor Cell Growth through Cytoplasmic Retention of NF-κB.Gene expression profiling and DNA methylation analyses of CTCs.Cystatin C properties crucial for uptake and inhibition of intracellular target enzymes.DNA hypermethyation and silencing of PITX1 correlated with advanced stage and poor postoperative prognosis of esophageal squamous cell carcinoma.Low-level internalization of cystatin E/M affects legumain activity and migration of melanoma cells.
P2860
Q33755220-0D914D5D-9F9B-496E-9FA8-7BC09F177E45Q33947935-AC62C1A5-3960-4741-B266-E13C474705D8Q34031843-B9F74DC4-35A6-4C73-B75F-8EE0D949BE96Q34200211-D9F2BECA-5A47-4DD8-8A16-425A4BECD021Q34454163-F7F7BC4F-CFC5-4A98-B826-775412005F43Q35798915-20637560-B3A1-4702-AD42-DB32D5E80E31Q36180739-3A9D3A83-CEF9-4F03-A930-A8671CE86150Q36210416-3C9B5E6D-6204-4CDE-B124-129DA8CDFAE2Q36287435-6615945F-08D4-4967-BD60-40B63AC1157BQ36882938-F5D396CA-4CE1-4016-8FF7-A3DBCC3B4FC4Q36921180-FE28DE93-4D32-4991-B6A1-05E09616CE74Q37002169-616DDC3E-8DCD-4FE5-A809-591CB4548D91Q38734877-DF5F0AB6-4D35-4E0E-9AD8-E4532CD4ACDCQ39158481-B2F0E63F-2299-4BDC-8779-197AF8931180Q47121817-90C03DC6-074C-4B8E-84FC-E17C23DBE57BQ50935834-CB13DD62-DC73-4EF6-A61B-9708BBEFDD92
P2860
Frequent loss of cystatin E/M expression implicated in the progression of prostate cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Frequent loss of cystatin E/M ...... rogression of prostate cancer.
@en
Frequent loss of cystatin E/M ...... rogression of prostate cancer.
@nl
type
label
Frequent loss of cystatin E/M ...... rogression of prostate cancer.
@en
Frequent loss of cystatin E/M ...... rogression of prostate cancer.
@nl
prefLabel
Frequent loss of cystatin E/M ...... rogression of prostate cancer.
@en
Frequent loss of cystatin E/M ...... rogression of prostate cancer.
@nl
P2093
P2860
P356
P1433
P1476
Frequent loss of cystatin E/M ...... rogression of prostate cancer.
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2009.134
P407
P577
2009-06-08T00:00:00Z